As BIO Digital kicks off today, we continue our BIO: Beyond Imagination series featuring the technology and scientific advancements of BIO member companies. Our newest post features SAB Biotherapeutics and its innovative approach for a potential COVID-19 treatment. Don’t miss SAB’s President and…

Our series, Biotechnology: Beyond Imagination, highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Our next feature looks at Alnylam Pharmaceuticals, a biotechnology company working on treatments for diseases that were once thought…

As we count down to BIO Digital, our BIO: Beyond Imagination series highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today’s feature is Sanofi and its work to develop a potential vaccine for COVID-19. Beyond Imagination Member…

Our next post in the Biotechnology: Beyond Imagination series highlights MaxCyte and the cell therapy technology the company has developed for researchers to accelerate, streamline and improve the drug development process. Beyond Imagination Member Spotlight: MaxCyte About half of the 300 million…

We highlight the technology and scientific advancements of BIO Digital participating companies and BIO member companies in our Biotechnology: Beyond Imagination series. Our next feature focuses on Sangamo Therapeutics and its work with gene therapy for a potential treatment for Alzheimer’s patients…

This is the second post in our series, Biotechnology: Beyond Imagination, which highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today’s feature focuses on INOVIO and its work to find a vaccine for COVID-19. Beyond Imagination…

Introducing Biotechnology: Beyond Imagination, a new series highlighting the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Featuring videos and blog posts that will enhance your understanding of technologies being…

As the novel coronavirus continues to spread, scientists and researchers are working around the clock to identify diagnostics, therapeutics and vaccines to help protect individuals and communities across the globe. This week, leaders within the biopharmaceutical industry took to the airwaves,…

“We will continue doing what we do best -- find new therapeutics to solve this crisis. Let’s all focus on this mission and not politics.” – Dr. Jeremy Levin, Biocentury Scientists and researchers at America’s biopharmaceutical companies are working around the clock to develop vaccines,…

By Debbie Hart, President & CEO of BIONJ As a leader within the New Jersey life sciences, ensuring that patients have affordable access to prescription medicines is a leading priority for my organization and the scientists and researchers we represent. We strongly believe that policymakers at…